Quality Improvement Initiatives to Assess and Improve PET/CT Injection Infiltration Rates at Multiple Centers
暂无分享,去创建一个
Pawan K Gupta | O. Mawlawi | D. Townsend | A. Mintz | J. Crowley | Shane C. Masters | T. Wong | T. Benefield | D. Osborne | Steven R. Perrin | J. Barnwell | J. Kiser | Ronald K. Lattanze | Kelley A Ryan
[1] Sarah A. Frye,et al. Usefulness of Topically Applied Sensors to Assess the Quality of 18F-FDG Injections and Validation Against Dynamic Positron Emission Tomography (PET) Images , 2018, Front. Med..
[2] J. Crowley,et al. Impact of an 18F-FDG PET/CT Radiotracer Injection Infiltration on Patient Management—A Case Report , 2018, Front. Med..
[3] D. Berman,et al. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC , 2017, The Journal of Nuclear Medicine.
[4] D. Townsend,et al. The Importance of Quality Control for Clinical PET Imaging , 2017, The Journal of Nuclear Medicine Technology.
[5] Sarah A. Frye,et al. Novel Method to Detect and Characterize 18F-FDG Infiltration at the Injection Site: A Single-Institution Experience , 2017, The Journal of Nuclear Medicine Technology.
[6] Yan Liu,et al. Guidelines for quality control of PET/CT scans in a multicenter clinical study , 2017, EJNMMI Physics.
[7] C. West,et al. Chemotherapy Extravasation: Establishing a national benchmark for incidence among cancer centers , 2017, Clinical journal of oncology nursing.
[8] T. Ruddy,et al. False-positive stress PET–CT imaging in a patient with interstitial injection , 2017, Journal of Nuclear Cardiology.
[9] D. Mankoff,et al. Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review , 2017, JAMA oncology.
[10] Sudheer D. Rani,et al. Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Koen Van Laere,et al. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0 , 2016, The Journal of Nuclear Medicine.
[12] Tomio Inoue,et al. Fever of unknown origin (FUO): evaluation of 50 cases with 18F-FDG PET/CT. , 2015 .
[13] Ion Codreanu,et al. Growing applications of FDG PET-CT imaging in non-oncologic conditions , 2015, Journal of biomedical research.
[14] M. Bhargavan-Chatfield,et al. Intravenous contrast extravasation during CT: a national data registry and practice quality improvement initiative. , 2015, Journal of the American College of Radiology : JACR.
[15] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[16] J. Mosquera,et al. Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies. , 2014, Medical physics.
[17] Yiyan Liu. Fluorodeoxyglucose uptake in absence of CT abnormality on PET-CT: What is it? , 2013, World journal of radiology.
[18] B. Sanghera,et al. FDG injection site extravasation: potential pitfall of misinterpretation and missing metastases. , 2012, Clinical nuclear medicine.
[19] A. Bhattacharya,et al. New axillary lymph nodal F-18 fluoro-deoxy glucose uptake in an interim positron emission tomography scan – not always a sign of disease progression , 2011, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.
[20] Hyunsuk Shim,et al. Metabolic positron emission tomography imaging in cancer detection and therapy response. , 2011, Seminars in oncology.
[21] F. S. Chew. Extravasation of iodinated contrast medium during CT: self-assessment module. , 2010, AJR. American journal of roentgenology.
[22] R. Boellaard. Standards for PET Image Acquisition and Quantitative Data Analysis , 2009, Journal of Nuclear Medicine.
[23] M. Osman,et al. FDG manual injection verses infusion system: A comparison of dose precision and extravasation , 2009 .
[24] M. Osman,et al. Contamination in 18F-FDG PET/CT: An initial experience , 2009 .
[25] M. Osman,et al. FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements , 2007, Front. Oncol..
[26] Steven Burrell,et al. Artifacts and pitfalls in myocardial perfusion imaging. , 2006, Journal of nuclear medicine technology.
[27] V. Lowe,et al. Normal variants and pitfalls in whole-body PET imaging with 18F FDG , 2006, Applied Radiology.
[28] G. Denardo. Editorial: "right place, wrong place": extravasation of therapeutic drug for molecular targeted radiotherapy. , 2006, Cancer biotherapy & radiopharmaceuticals.
[29] M. Knopp,et al. Impact of FDG extravasation on SUV measurements in clinical PET/CT. Should we routinely scan the injection site? , 2006 .
[30] V. Ambrosini,et al. Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings , 2005, Nuclear medicine communications.
[31] Wolfgang A Weber,et al. Use of PET for monitoring cancer therapy and for predicting outcome. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] Thomas Beyer,et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] A. Alavi,et al. Potential false-positive FDG PET imaging caused by subcutaneous radiotracer infiltration. , 2003, Clinical nuclear medicine.
[34] D. Binns,et al. Inadvertent 2-deoxy-2-[18F]fluoro-D-glucose lymphoscintigraphy: a potential pitfall characterized by hybrid PET-CT. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[35] M. Spieth,et al. A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] K. Rezai,et al. Incidental Lymph Node Visualization on Bone Scan Due to Subcutaneous Infiltration of Tc‐99m MDP A Potential for False Positive Interpretation , 1993, Clinical nuclear medicine.
[37] R. Wahl,et al. 99Tcm-MDP uptake by lymph nodes following tracer infiltration: clinical and laboratory evaluation , 1987, Nuclear medicine communications.
[38] H. Shim,et al. Metabolic PET Imaging in Cancer Detection and Therapy Response , 2011 .
[39] The Role of PET / CT in Radiation Treatment Planning for Cancer Patient Treatment , 2008 .
[40] C. Engelking,et al. Vesicant extravasation: myths and realities. , 1995, Oncology nursing forum.